• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- Type A blood linked to higher rate of COVID infections

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/covid-19/type-blood-linked-higher-rate-covid-infections

Type A blood linked to higher rate of COVID infections



Stephanie Soucheray, MA


Today at 4:57 p.m.

COVID-19
People with type A blood are likely more susceptible to COVID-19 infections, because the spike protein of the virus shows an affinity for blood group A cells, according to a new study in Blood.

This is the strongest evidence to date to support the idea that blood types influence who is more likely to contract COVID-19.

Moreover, the study shows the spike protein's affinity for type A cells may be amplified by the Omicron strain of the virus.

Lab tests show 25 to 50% increased infection for type A


The study looked at the receptor binding domain (RBD) of SARS-CoV-2, which facilitates host cell engagement. RBD is very similar to galectins, a family of carbohydrate binding proteins that can be studied in a lab setting.

Blood group antigens are carbohydrates, so the authors compared the glycan binding specificity of the SARS-COV-2 RBD with galectins in blood cells from both type A and O. The SARS-CoV-2 virus showed a strong affinity for type A cells. Depending on what virus variant was used, a likelihood of infection increased by 25% to 50% compared to type O cells.

Not only did each RBD recognize blood group A in a glycan array format, the authors explained mutations in variant strains of the virus can be found in regions of the RBD predicted to recognize glycans. Those changes enhanced blood group A binding, the authors said.

Other risk factors more important


These lab findings match clinical observations, which show people with type A blood have demonstrated as much as a 47% increase in likelihood to get infected with COVID-19.

Among a group of several thousand people, some studies suggest that those with blood group A may be 20% more likely to be infected.

"Among a group of several thousand people, some studies suggest that those with blood group A may be 20% more likely to be infected after exposure to SARS-CoV-2 compared with those who have blood group O. But people with blood group O can still contract the virus and may transmit it to others," said Sean R. Stowell, MD, PhD, of Harvard Medical School, in a press release.

Stowell said, though important, blood type does not rank as high as factors such as age and chronic conditions in determining individuals' risk for severe SARS-CoV-2 infection.

"Blood group is one of many variables that influence one's likelihood of becoming infected following exposure to SARS-CoV-2," he said. "Regardless of their blood group, individuals should be fully vaccinated against COVID-19 and should continue to take other preventive measures appropriate to their risk level."
 
Back
Top Bottom